Oliver Burk
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism 36
- Drug-Induced Hepatotoxicity and Protection 8
- Transplantation top 0.5%
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 38
-
- Pharmacological Effects and Toxicity Studies 10
-
- Hormonal Regulation and Hypertension 8
-
- HIV/AIDS drug development and treatment 6
-
- Protein Kinase Regulation and GTPase Signaling 5
-
- Estrogen and related hormone effects 5
- Co-authors
- Michel EichelbaumAnke GeickUlrich M. ZangerOliver von RichterUlrich BrinkmannMatthias SchwabSven HoffmeyerLeszek Wojnowski
- Cited by
- PharmacologyTransplantationOncology
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Molecular Pharmacology (5 papers)Archives of Toxicology (4 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Oliver Burk
66 papers receiving 7.9k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Pharmacology 3.4k
- Transplantation 492
- Oncology 4.5k
- Pediatrics, Perinatology and Child Health 2.4k
- Endocrinology, Diabetes and Metabolism 827
Countries citing papers authored by Oliver Burk
This map shows the geographic impact of Oliver Burk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Burk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Burk more than expected).
Fields of papers citing papers by Oliver Burk
This network shows the impact of papers produced by Oliver Burk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Burk. The network helps show where Oliver Burk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oliver Burk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2021 | 9 | |
| 4 | 2015 | 9 | |
| 5 | 2015 | 25 | |
| 6 | 2013 | 73 | |
| 7 | 2012 | 16 | |
| 8 | 2012 | 30 | |
| 9 | 2011 | 49 | |
| 10 | 2010 | 39 | |
| 11 | 2009 | 306 | |
| 12 | 2007 | 220 | |
| 13 | 2007 | 20 | |
| 14 | 2007 | 22 | |
| 15 | 2006 | 14 | |
| 16 | 2004 | 113 | |
| 17 | 2002 | 156 | |
| 18 | Induction of CYP2C8, CYP2C9, and CYP3A4 by rifampin in shedded human enterocytes. | 2001 | 1 |
| 19 | Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampinbreakdown → | 2001 | 702 |
| 20 | 2000 | 208 |
About Oliver Burk
Oliver Burk is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 68 papers that have together received 8.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (38 papers), Pharmacogenetics and Drug Metabolism (36 papers), Pharmacological Effects and Toxicity Studies (10 papers), Hormonal Regulation and Hypertension (8 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), HIV/AIDS drug development and treatment (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Pharmacology (3.4k citations), Transplantation (492 citations) and Oncology (4.5k citations). Oliver Burk has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Michel Eichelbaum, Anke Geick, Ulrich M. Zanger, Oliver von Richter, Ulrich Brinkmann, Matthias Schwab, Sven Hoffmeyer, Leszek Wojnowski, J. Brockmöller and Ingolf Cascorbi. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Molecular Pharmacology, Archives of Toxicology, Journal of Biological Chemistry and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.